Site Members can sign up for company wide alerts
Investigation Overview
May 29, 2013 (Shareholders Foundation) - An investigation on behalf of investors in Omthera Pharmaceuticals Inc (NASDAQ:OMTH) shares was announced concerning whether the offer by AstraZeneca to acquire Omthera Pharmaceuticals Inc for $12.70 per NASDAQ:OMTH share and the takeover process are unfair to investors in NASDAQ:OMTH shares. The investigation by a law firm concerns whether cer...
You must register (for free) or login to view the entire investigation.